Review
Copyright ©The Author(s) 2020.
World J Radiol. Jun 28, 2020; 12(6): 87-100
Published online Jun 28, 2020. doi: 10.4329/wjr.v12.i6.87
Table 3 Utilized acquisition parameters for 11C-PiB, 18F florbetapir, and 18F florbetaben studies for cardiac amyloidosis[50-52]
Imaging considerationsParameters
Patient and equipment preparation
Patient preparationNo prerequisites, no fasting
PositionSupine arms above shoulder or supported
ScanRest scan
Dose11C-PiB 10-20 mCi (370-740 MBq) IV[50]
18F florbetapir 6 mCi (222 MBq) IV[51]
18F florbetaben 0.1 mCi/kg (4 MBq/kg) IV[52]
Time from injection to acquisition11C-PiB 30 min[50]
18F florbetapir continuous over 60 min[51]
18F florbetaben continuous over 80 min[52]
Scan parameters
Field of viewHeart; Chest
Image typeLow-dose (10 mA, 120 kVp, free tidal breathing) CT scout scan
Low-dose CT transmission scan (10 mA, 120 kVp, free tidal breathing) over the heart
Emission scan 2D 40-60 mCi (1480-2220 MBq)
Emission scan 3D 10-20 mCi (370-740 MBq)
Matrix128 × 128-400 × 400
ReconstructionFiltered back projection or iterative reconstruction